NEUE PHOSPHOR ENTHALTENDE THYROMIMETIKA

Patent europeic · EP1689383 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1689383
Numer da la dumonda
EP04811701
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
19-11-2004
Publitgà
16-08-2006
Concedì
31-10-2012
Stritgà
30-11-2012
Motiv
Taxa annuala betg pajada
Classas IPC
C07F 9/30 (2006.01)
A61K 31/28 (2006.01)
A61K 31/445 (2006.01)
A61K 31/435 (2006.01)
C07F 9/06 (2006.01)
A61P 5/18 (2006.01)
Prioritad
US 523830 P 19.11.2003
US 598524 P 03.08.2004
Dumonda PCT
PCT/US2004/039024 19.11.2004
Publicaziun PCT
WO2005/051298 09.06.2005
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 19-06-2013

    Stritgà, taxa betg pajada

    Published in Swissreg on 19.06.2013

  2. 31-10-2012

    Concedì

    Published in Swissreg on 31.10.2012

Partidas

Possessur

Metabasis Therapeutics, Inc.

11085 North Torrey Pines Road Suite 300, La Jolla, CA 92037, US

Inventur

ERION, Mark, D.

Del Mar, CA 92104, US

JIANG, Hongjian

San Diego, CA 92129, US

BOYER, Serge, H.

San Diego, CA 92109, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.